Intriguingly, the expression of a TAF4 histone-fold fragment squelched TAF12 and thereby suppressed MYB oncogenic activity, both in AML cells in vitro and in an in vivo mouse model of AML. The gene discussed is TAF4; the disease is acute myeloid leukemia.